We are the blood
pressure people

Our engineers, scientists, and mission-driven visionaries utilize unique datasets and deep learning algorithms, advancing beyond conventional blood pressure metrics to redefine proactive health standards.

Company overview

We turn insights into action in the fight against hypertension

At Hilo, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care.

Aktiia Co-Founders start working

Josep and Mattia join the Swiss Centre for Electronics and Microtechnology (CSEM)

Cuffless Blood Pressure R&D Process

30+ techniques tested, 10+ studies conducted;
1 proven solution: Optical Blood Pressure Monitoring

Josep Solà defends his PhD thesis

His research on continuous non-invasive BP estimation is the technology behind Aktiia’s monitoring solutions.

Aktiia is founded

Clinical Trial Confirms Accuracy of Cuffless BP Monitoring

Aktiia’s clinical trial, highlighted in Blood Pressure Monitoring journal, demonstrates its optical device’s accuracy in measuring blood pressure without cuffs, compared to traditional arterial line methods.

Aktiia's Clinical Trial Validates Cuffless BP Monitoring Versus Auscultation

Aktiia’s trial successfully compares its cuffless BP monitoring technology against traditional auscultation methods, ensuring accuracy during posture changes. This supports the device’s use for consistent 24-hour blood pressure tracking.

Aktiia earns the CE mark

Aktiia is classified as a Class IIa Medical Device, adhering to the highest safety and performance standards in the European Union.

Aktiia debuts in the UK Market

Aktiia continues its expansion, offering its advanced health monitoring technologies to the UK audience.

1 Million Readings

Aktiia launches in Six European Markets

Aktiia brings its cutting-edge solution to Germany, Switzerland, France, Italy, Austria and Ireland.

4 Million Readings

Nature Cardiology Reviews features Aktiia data

20 Million Readings

Nature Publication Validates Aktiia's Blood Pressure Monitor Accuracy

Published in Nature Scientific Reports, Aktiia’s study demonstrates the consistent accuracy of its wearable blood pressure monitor across different body positions.

30 Million Readings

50 Million Blood Pressure Measurements

Aktiia Study in Nature Shows Cuffless Monitor on Par with 24-h Daytime ABPM

Aktiia’s cuffless BP monitor is validated by a Nature Hypertension study, showing equivalent accuracy to 24-hour ambulatory monitoring in cardiac rehab patients.

100 Million Readings

150 Million Readings

Study of Aktiia device in the elderly

Evaluating its performance in different body positions with auscultation as the reference measurement.

Aktiia's Global Research Footprint Expands

Aktiia’s blood pressure technology is at the forefront of medical innovation, participating in over 20 clinical trials worldwide to improve patient care and health outcomes.

200 Million Readings

CE mark for CALFREE technology

App gets approval to provide accurate blood pressure and heart rate measurements using a smartphone camera.

Aktiia launches in Canada, its 8th market

Expansion continues with entry into the Canadian market.

Aktiia G1 becomes Hilo Band and launches in Spain, Australia, Liechtenstein, and Luxembourg

Expansion continues with entry into the Canadian market.

Aktiia raises $42M in series B

Funding boosts the company’s growth and development.

Aktiia G0 receives FDA approval

FDA clearance for the G0 device, paving the way for G1 and future approvals.

OUR MISSION

It’s our mission to manage the world’s blood pressure.

The unique data from Hilo’s automated 24/7 blood pressure solution leads to never-before-possible insights about cardiovascular health.

OUR MISSION

It’s our mission to manage the world’s blood pressure.

The unique data from Hilo’s automated 24/7 blood pressure solution leads to never-before-possible insights about cardiovascular health.

oUR EXPERTS

Hilo’s team of experts has:

At Hilo, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care.

4 PhD’s in biomedical signal processing

Over 120 peer-reviewed publications

Over 35 collective patents

Member of ISO/IEEE committees

Editor of “Cuffless Blood Pressure Handbook”

4 PhD’s in biomedical signal processing

Over 120 peer-reviewed publications

Over 35 collective patents

Member of ISO/IEEE committees

Editor of “Cuffless Blood Pressure Handbook”

Leadership team:

Stefan Petzinger

Chief Executive Officer

Dipl. Kfm., Master of Business Administration, University of Hamburg

Mattia Bertschi

Chief Executive Officer

Ph.D. in Biomedical Engineering from the Swiss Federal Institute of Technology in Lausanne

Josep Solà

Chief Technology Officer

Ph.D. in Telecommunications from the Swiss Federal Institute of Technology in Zurich

Mathieu Danthony

VP Finance

MS in Finance, CPA, 13+ years of international finance experience

Nadege Siutryk

Senior Director of Software Engineering

MA in Electronics Engineering with a specialization in Microelectronics

Neil Puri

VP Quality & Regulatory

NHS Professor of Cardiovascular Medicine, Director Barts BP Clinic

Built on expertise, reinforced by data

Backed by the best in the business

Dr. Christoph Massner

Healthcare Investor at Earlybird Venture Capital

“Hilo stands at the intersection of medical-grade precision and consumer-centric  accessibility. By building on a validated medical device platform and an intuitive, user-friendly design, they bridge the gap between clinical reliability and everyday usability. It’s a rare combination that empowers users to take meaningful control of their health with minimal effort. This is especially critical given the enormous medical need: uncontrolled high blood pressure remains one of the leading risk factors for death worldwide.”